BREZTRI REGULATORY POST MARKETING SURVEILLANCE IN KOREA
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma
At a glance
- Phase
- Phase not stated
- Study type
- Observational
- Sponsor
- AstraZeneca
- Enrolment target
- 600
- Started
- 17 September 2026
- Main results due
- 31 July 2027
- Study sites
- 10
- Registry updated
- 23 September 2026
Can you take part?
- No age limit is stated.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: 1. Patients who have been diagnosed with COPD or asthma. 2. Patients who have newly initiated treatment with Breztri according to the approved label in Korea 3. Provision of signed and dated written informed consent by the patient or legally acceptable representative Exclusion Criteria: 1. Other off-label indications outside of the locally approved prescribing information 2. Pregnant and/or breast feeding 3. Current participation in any interventional trial
What this study is about
In the sponsor’s own words, from the registry.
As part of a post-approval commitment requested by the Ministry of Food and Drug Safety (MFDS), this open-label, single-arm, multicentre, observational Post-Marketing Surveillance (PMS) study aims to characterize the safety profile of Breztri in real-world clinical practice settings, either confirming known safety outcomes or identifying previously unsuspected adverse drug reactions. The study will also evaluate effectiveness of Breztri in real-world clinical practice settings, generating essential clinical evidence from a broader and more diverse Korean patient population representative of daily medical practice.
Study sites(10)
Research Site
Chuncheon, South Korea
Not yet recruiting
Research Site
Daegu, South Korea
Recruiting
Research Site
Goyang-si, South Korea
Not yet recruiting
Research Site
Gwangmyeong, South Korea
Not yet recruiting
Research Site
Jinju, South Korea
Not yet recruiting
Research Site
Seongnam-si, South Korea
Recruiting
Research Site
Seongnam-si, South Korea
Not yet recruiting
Research Site
Seoul, South Korea
Recruiting
Research Site
Seoul, South Korea
Not yet recruiting
Research Site
Wŏnju, South Korea
Recruiting
Showing 10 of 10 sites. 4 of the 10 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07570394. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me